$0.81 EPS Expected for DENTSPLY SIRONA Inc (XRAY) This Quarter

Analysts expect that DENTSPLY SIRONA Inc (NASDAQ:XRAY) will post $0.81 earnings per share (EPS) for the current quarter, Zacks reports. Nine analysts have provided estimates for DENTSPLY SIRONA’s earnings, with the highest EPS estimate coming in at $0.82 and the lowest estimate coming in at $0.80. DENTSPLY SIRONA posted earnings of $0.67 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 20.9%. The business is expected to issue its next quarterly earnings results on Friday, February 16th.

On average, analysts expect that DENTSPLY SIRONA will report full-year earnings of $2.65 per share for the current fiscal year, with EPS estimates ranging from $2.65 to $2.67. For the next fiscal year, analysts forecast that the business will report earnings of $2.90 per share, with EPS estimates ranging from $2.80 to $3.03. Zacks’ earnings per share calculations are a mean average based on a survey of analysts that follow DENTSPLY SIRONA.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.66 by $0.04. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The business had revenue of $1.01 billion for the quarter, compared to analyst estimates of $978.99 million. During the same period last year, the company posted $0.66 EPS. The business’s revenue was up 5.8% on a year-over-year basis.

A number of research analysts have weighed in on the stock. HC Wainwright lowered shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and set a $68.00 target price on the stock. in a research note on Thursday, November 30th. Zacks Investment Research lowered shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday, January 8th. Stephens assumed coverage on shares of DENTSPLY SIRONA in a research note on Tuesday, November 28th. They issued an “overweight” rating and a $75.00 target price on the stock. Credit Suisse Group lowered shares of DENTSPLY SIRONA to a “hold” rating and set a $73.00 target price on the stock. in a research note on Friday, January 5th. Finally, BidaskClub lowered shares of DENTSPLY SIRONA from a “strong-buy” rating to a “buy” rating in a research report on Saturday, December 2nd. Two analysts have rated the stock with a sell rating, four have issued a hold rating and nine have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $69.15.

DENTSPLY SIRONA (NASDAQ XRAY) opened at $65.79 on Friday. The company has a quick ratio of 1.59, a current ratio of 2.32 and a debt-to-equity ratio of 0.21. DENTSPLY SIRONA has a 12 month low of $52.53 and a 12 month high of $68.98. The firm has a market cap of $15,110.84, a P/E ratio of -18.96, a price-to-earnings-growth ratio of 2.42 and a beta of 1.31.

The company also recently declared a quarterly dividend, which was paid on Friday, January 12th. Stockholders of record on Friday, December 29th were given a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a dividend yield of 0.53%. The ex-dividend date of this dividend was Thursday, December 28th. DENTSPLY SIRONA’s payout ratio is presently -10.09%.

In other news, insider Mark Thierer bought 77,000 shares of the business’s stock in a transaction on Monday, November 13th. The shares were bought at an average price of $66.04 per share, with a total value of $5,085,080.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Nicholas W. Alexos bought 50,000 shares of the business’s stock in a transaction on Monday, November 13th. The stock was purchased at an average cost of $65.85 per share, for a total transaction of $3,292,500.00. The disclosure for this purchase can be found here. 1.99% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in XRAY. Federated Investors Inc. PA raised its position in DENTSPLY SIRONA by 258.6% in the second quarter. Federated Investors Inc. PA now owns 5,486 shares of the medical instruments supplier’s stock valued at $356,000 after purchasing an additional 3,956 shares during the period. Los Angeles Capital Management & Equity Research Inc. purchased a new stake in DENTSPLY SIRONA in the second quarter valued at approximately $764,000. Commonwealth Bank of Australia raised its position in DENTSPLY SIRONA by 19.0% in the second quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock valued at $104,000 after purchasing an additional 260 shares during the period. Wells Fargo & Company MN raised its position in DENTSPLY SIRONA by 24.8% in the second quarter. Wells Fargo & Company MN now owns 855,877 shares of the medical instruments supplier’s stock valued at $55,496,000 after purchasing an additional 169,844 shares during the period. Finally, Stephens Inc. AR raised its position in DENTSPLY SIRONA by 2.7% in the second quarter. Stephens Inc. AR now owns 11,456 shares of the medical instruments supplier’s stock valued at $743,000 after purchasing an additional 305 shares during the period. 96.14% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “$0.81 EPS Expected for DENTSPLY SIRONA Inc (XRAY) This Quarter” was posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this piece of content can be read at https://www.com-unik.info/2018/01/14/0-81-eps-expected-for-dentsply-sirona-inc-xray-this-quarter.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit